Pieter Cohen
speaker
130 appearances
1 recordings
1 series
first heard Jan 2026
last heard 9 Jan
Pieter Cohen’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jan 2026 with 1.
Appearances
There's been a lot of questions over the decades about the quality of products, in part because of studies like ours demonstrating that everything is not exactly as it might appear on the label.
These groups are only looking at the chemical compounds found in the supplement and are not making any assessment.
of the health claims or structure function claims or you name it.
I don't know of a single organization that's doing that in any sort of accurate way.
You know, taking a look at the labels and saying, is this truthful or is this supported by solid science?
Yeah, I mean, it's very distorted and I'm really struggling between zero and one.
I don't know if I can do fractions, but it would be somewhere there.
As long as the manufacturer avoids mentioning a specific disease like Alzheimer's disease.
they can suggest that their product has that health benefit, the same one that anyone with Alzheimer's disease or with a loved one with Alzheimer's disease would be thinking about.
So the manufacturer, if we were manufacturing supplements, could promote our product as if it maintains a healthy memory or preserves healthy memory or memory boosting.
All these are legal claims, even if your product has never been studied in humans at all.
Yeah, the pharmaceutical is a completely different situation.
In order for a pharmaceutical to make a claim, it would have to have been approved by the FDA.
Large clinical trials need to be conducted.
The FDA needs to first approve the pharmaceutical for human use.
And when they do that, they'll also be clear on what the approved uses are.
And traditionally, manufacturers have been required to stick with the claims that they had originally got approval for.
And beyond that, they couldn't comment on the use of their drug.
How a manufacturer can look at it is if they have some compound they want to sell, some health compound, they just need to decide which is the more profitable route.
It might be that doing large randomized controlled trials and then having proprietary control over it and being able to have the stamp of approval of the FDA as a prescription drug and then being able to sell that globally will be the most profitable.
Showing 1–20 of 130 · page 1 of 7
Next →